Showing results (391-400 of 536) with videos related to
Sort By:
Pageof 54
The Journal of Surgical Research|February 9, 2021
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care InitiativeCasey J Allen, Jarrod S Eska, Nikhil G Thaker, et al.The Journal of Surgical Research|March 20, 2022
Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After PancreatectomyRussell G Witt, Timothy E Newhook, Laura R Prakash, et al.Annals of Surgical Oncology|October 30, 2014
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancerChristina L Roland, Anthony D Yang, Matthew H G Katz, et al.Journal of Hepato-Biliary-Pancreatic Sciences|July 7, 2022
Comparative analysis of opioid use between robotic and open pancreatoduodenectomyRussell G Witt, Yuki Hirata, Laura R Prakash, et al.Annals of Surgical Oncology|September 10, 2015
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyChristina L Roland, Matthew H G Katz, Ching-Wei D Tzeng, et al.The Journal of Investigative Dermatology|June 10, 2019
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma ProgressionShenying Fang, Tao Xu, Momiao Xiong, et al.Annals of Surgery|January 3, 2020
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic AdenocarcinomaGiampaolo Perri, Laura Prakash, Wei Qiao, et al.Annals of Surgery|December 1, 2018
Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After PancreatectomyTimothy E Newhook, Timothy J Vreeland, Whitney L Dewhurst, et al.The American Journal of Surgical Pathology|February 4, 2012
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane, Gauri R Varadhachary, John S Yordy, et al.Pageof 54